• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Bionor Pharma ASA

+ Add to Watchlist

NU5:GR

0.251 EUR 0.011 4.20%

As of 02:02:16 ET on 10/21/2014.

Snapshot for Bionor Pharma ASA (NU5)

Open: 0.256 Day's Range: 0.251 - 0.256 Volume: 0
Previous Close: 0.262 52wk Range: 0.220 - 0.513 1-Yr Rtn: -22.29%

Stock Chart for NU5

No chart data available.
  • NU5:GR 0.251
  • 1D
  • 1M
  • 1Y
0.262
Interactive NU5 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NU5

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (NOK) (ttm) -
Est. EPS (NOK) (12/2014) -0.2800
Est. PEG Ratio -
Market Cap (M EUR) 62.33
Shares Outstanding (M) 248.33
30 Day Average Volume 23
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend (NOK) 2.6785
Dividend Ex-Date 12/12/2003
5 Year Dividend Growth -
Next Earnings Announcement 11/04/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NU5

  • Revenue
  • Net Income (M/NOK)
  • Profit Margin (%)

Company Profile & Key Executives for NU5

Bionor Pharma ASA is a biotechnology company. The Company develops therapeutic peptide vaccines that stimulate cell-mediated immunity. Bionor Pharma targets diseases that include chronic infections such as HIV, Hepatitis C (HCV), Human Papilloma Virus (HPV) and Influenza.

Steen KroyerDeputy ChairmanAnker LundemosePresident/CEO
Synne H RoineChief Financial OfficerVidar Wendel-HansenChief Medical Officer
More Company Profile & Key Executives for NU5

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil